HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Habib Zarredar Selected Research

Communicable Diseases (Infectious Diseases)

12/2021Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.
1/2014The search for a promising cell factory system for production of edible vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Habib Zarredar Research Topics

Disease

19Neoplasms (Cancer)
01/2024 - 10/2014
7Lung Neoplasms (Lung Cancer)
01/2023 - 01/2018
4Carcinogenesis
10/2023 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2023 - 01/2018
3Adenocarcinoma of Lung
01/2019 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 09/2022
2COVID-19
08/2022 - 12/2021
2Communicable Diseases (Infectious Diseases)
12/2021 - 01/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2019 - 01/2019
1Obesity
12/2023
1Papillary Thyroid Cancer
10/2023
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023
1Neuroblastoma
03/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Heart Failure
01/2022
1Infections
12/2021
1Rheumatoid Arthritis
06/2018
1Autoimmune Diseases (Autoimmune Disease)
06/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Circulating Neoplastic Cells
01/2018
1Ascites
01/2018
1Fibrosarcoma
10/2014

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2021
4MicroRNAs (MicroRNA)IBA
01/2023 - 01/2018
4Small Interfering RNA (siRNA)IBA
09/2022 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
2MicronutrientsIBA
08/2022 - 12/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
2AZD 8931IBA
01/2019 - 01/2019
1LeptinIBA
12/2023
1Mitogen-Activated Protein Kinase 14IBA
10/2023
1Histones (Histone)IBA
01/2023
1Toll-Like Receptor 4IBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1EnzymesIBA
01/2023
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
01/2023
1NADP (NADPH)IBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1Thymidylate SynthaseIBA
12/2022
1SolventsIBA
03/2022
1AntioxidantsIBA
12/2021
1VitaminsIBA
12/2021
1Plant ExtractsIBA
04/2021
1Long Noncoding RNAIBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
01/2019
1SurvivinIBA
09/2018
1catumaxomabIBA
01/2018
1AntigensIBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1AntibodiesIBA
01/2018
1Epithelial Cell Adhesion MoleculeIBA
01/2018
1AntagomirsIBA
01/2018
1OligonucleotidesIBA
01/2018
1Glycoproteins (Glycoprotein)IBA
01/2018
1adecatumumabIBA
01/2018
1Neoplasm Antigens (Tumor Antigens)IBA
01/2018
1Immunomodulating AgentsIBA
10/2014
1Thalidomide (Thalomid)FDA Link
10/2014
1VaccinesIBA
01/2014

Therapy/Procedure

12Therapeutics
10/2023 - 10/2014
2Drug Therapy (Chemotherapy)
01/2018 - 10/2014
1Immunotherapy
01/2024
1Aftercare (After-Treatment)
09/2022
1Adjuvant Chemotherapy
01/2019
1Radiotherapy
10/2014